Clinical Trial Update: Sacubitril Valsartan in Preventing the Recurrence of Atrial Fibrillation After Ablation in Elderly Hypertensive Patients With Atrial Fibrillation [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated Sacubitril/Valsartan for preventing recurrence of atrial fibrillation after ablation in elderly patients with hypertension; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Hypertension

Drugs mentioned

• Sacubitril/Valsartan (sacubitril/valsartan)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Atrial Fibrillation Recurrent, Hypertension | Phase 4 | Status: COMPLETED